Skip to main content

Poly(lactic-co-glycolic acid)/Polycaprolactone Nanofibrous Membranes for High-Efficient Capture of Nano- and Microsized Particulate Matter

Buy Article:

$107.14 + tax (Refund Policy)

The incidence of many diseases is closely related to air pollution. Suspended particulate matter of different sizes represents a major source of environmental pollution. Fine particles, especially ultrafine particles smaller than 2.5 μm, might be more harmful to human health because of their extremely small size, which enables them to penetrate human lungs and bronchi and makes them difficult to filter out. Therefore, the fatal risks associated with PM call for the development of air purification materials with high efficiency and low resistance. In this study, poly(lactic-co-glycolic acid) and polycaprolactone were used to prepare nanofibrous membranes suitable for the efficient capture of particulate matter formed in haze-fog episodes, especially particles smaller than 0.5 μm. The present nanofibrous membranes exhibit superior filtration efficiency for particulate matter, with a much lower pressure drop compared to typical commercial microfiber air filters. Thanks to the combination of small pore size, high porosity, and robust mechanical properties, the poly(lactic-co-glycolic acid)/polycaprolactone (6:4) composite membrane exhibits a high filtration efficiency of 97.81% and a low pressure drop of 181 Pa. These favorable features, combined with the easy availability and biocompatibility of the component materials, highlight the promising potential of the present nanofibrous membranes for the development of personal wearable air purifiers.

Keywords: AIR FILTER; EFFICIENCY; ELECTROSPINNING; NANOFIBROUS MEMBRANE; PARTICULATE MATTER

Document Type: Research Article

Publication date: 01 January 2018

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content